Literature DB >> 28132692

A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.

Kelly Schoch1, Linyan Meng2, Szabolcs Szelinger3, David R Bearden4, Asbjorg Stray-Pedersen5, Oyvind L Busk6, Nicholas Stong7, Eriskay Liston8, Ronald D Cohn9, Fernando Scaglia10, Jill A Rosenfeld11, Jennifer Tarpinian12, Cara M Skraban13, Matthew A Deardorff13, Jeremy N Friedman14, Zeynep Coban Akdemir15, Nicole Walley1, Mohamad A Mikati16, Peter G Kranz17, Joan Jasien16, Allyn McConkie-Rosell1, Marie McDonald1, Stephanie Burns Wechsler18, Michael Freemark19, Sujay Kansagra16, Sharon Freedman20, Deeksha Bali21, Francisca Millan22, Sherri Bale22, Stanley F Nelson23, Hane Lee24, Naghmeh Dorrani25, David B Goldstein7, Rui Xiao2, Yaping Yang2, Jennifer E Posey26, Julian A Martinez-Agosto27, James R Lupski28, Michael F Wangler29, Vandana Shashi30.   

Abstract

Whole-exome sequencing (WES) has increasingly enabled new pathogenic gene variant identification for undiagnosed neurodevelopmental disorders and provided insights into both gene function and disease biology. Here, we describe seven children with a neurodevelopmental disorder characterized by microcephaly, profound developmental delays and/or intellectual disability, cataracts, severe epilepsy including infantile spasms, irritability, failure to thrive, and stereotypic hand movements. Brain imaging in these individuals reveals delay in myelination and cerebral atrophy. We observe an identical recurrent de novo heterozygous c.892C>T (p.Arg298Trp) variant in the nucleus accumbens associated 1 (NACC1) gene in seven affected individuals. One of the seven individuals is mosaic for this variant. NACC1 encodes a transcriptional repressor implicated in gene expression and has not previously been associated with germline disorders. The probability of finding the same missense NACC1 variant by chance in 7 out of 17,228 individuals who underwent WES for diagnoses of neurodevelopmental phenotypes is extremely small and achieves genome-wide significance (p = 1.25 × 10-14). Selective constraint against missense variants in NACC1 makes this excess of an identical missense variant in all seven individuals more remarkable. Our findings are consistent with a germline recurrent mutational hotspot associated with an allele-specific neurodevelopmental phenotype in NACC1.
Copyright © 2017 American Society of Human Genetics. All rights reserved.

Entities:  

Keywords:  NACC1; cataracts; developmental/intellectual disabilities; epilepsy; irritability; microcephaly; stereotypy; whole-exome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28132692      PMCID: PMC5294886          DOI: 10.1016/j.ajhg.2016.12.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.043


  46 in total

1.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

2.  Biological role and prognostic significance of NAC1 in ovarian cancer.

Authors:  Kentaro Nakayama; Mohammed Tanjimur Rahman; Munmun Rahman; Shamima Yeasmin; Masako Ishikawa; Atsuko Katagiri; Kouji Iida; Naomi Nakayama; Kohji Miyazaki
Journal:  Gynecol Oncol       Date:  2010-09-24       Impact factor: 5.482

3.  A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival.

Authors:  Kentaro Nakayama; Naomi Nakayama; Ben Davidson; Jim J-C Sheu; Natini Jinawath; Antonio Santillan; Ritu Salani; Robert E Bristow; Patrice J Morin; Robert J Kurman; Tian-Li Wang; Ie-Ming Shih
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-27       Impact factor: 11.205

4.  GeneMatcher: a matching tool for connecting investigators with an interest in the same gene.

Authors:  Nara Sobreira; François Schiettecatte; David Valle; Ada Hamosh
Journal:  Hum Mutat       Date:  2015-08-13       Impact factor: 4.878

Review 5.  De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention.

Authors:  Julie Gauthier; Guy A Rouleau
Journal:  Genome Med       Date:  2012-09-25       Impact factor: 11.117

6.  NAC1, a POZ/BTB protein that functions as a corepressor.

Authors:  Laxminarayana Korutla; Peijie Wang; Trevor G Jackson; Scott A Mackler
Journal:  Neurochem Int       Date:  2008-12-13       Impact factor: 3.921

7.  Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma.

Authors:  Ie-Ming Shih; Kentaro Nakayama; Gang Wu; Naomi Nakayama; Jinghui Zhang; Tian-Li Wang
Journal:  Mod Pathol       Date:  2011-01-14       Impact factor: 7.842

8.  Genome-wide patterns and properties of de novo mutations in humans.

Authors:  Laurent C Francioli; Paz P Polak; Amnon Koren; Androniki Menelaou; Sung Chun; Ivo Renkens; Cornelia M van Duijn; Morris Swertz; Cisca Wijmenga; Gertjan van Ommen; P Eline Slagboom; Dorret I Boomsma; Kai Ye; Victor Guryev; Peter F Arndt; Wigard P Kloosterman; Paul I W de Bakker; Shamil R Sunyaev
Journal:  Nat Genet       Date:  2015-05-18       Impact factor: 38.330

9.  De novo mutations in epileptic encephalopathies.

Authors:  Andrew S Allen; Samuel F Berkovic; Patrick Cossette; Norman Delanty; Dennis Dlugos; Evan E Eichler; Michael P Epstein; Tracy Glauser; David B Goldstein; Yujun Han; Erin L Heinzen; Yuki Hitomi; Katherine B Howell; Michael R Johnson; Ruben Kuzniecky; Daniel H Lowenstein; Yi-Fan Lu; Maura R Z Madou; Anthony G Marson; Heather C Mefford; Sahar Esmaeeli Nieh; Terence J O'Brien; Ruth Ottman; Slavé Petrovski; Annapurna Poduri; Elizabeth K Ruzzo; Ingrid E Scheffer; Elliott H Sherr; Christopher J Yuskaitis; Bassel Abou-Khalil; Brian K Alldredge; Jocelyn F Bautista; Samuel F Berkovic; Alex Boro; Gregory D Cascino; Damian Consalvo; Patricia Crumrine; Orrin Devinsky; Dennis Dlugos; Michael P Epstein; Miguel Fiol; Nathan B Fountain; Jacqueline French; Daniel Friedman; Eric B Geller; Tracy Glauser; Simon Glynn; Sheryl R Haut; Jean Hayward; Sandra L Helmers; Sucheta Joshi; Andres Kanner; Heidi E Kirsch; Robert C Knowlton; Eric H Kossoff; Rachel Kuperman; Ruben Kuzniecky; Daniel H Lowenstein; Shannon M McGuire; Paul V Motika; Edward J Novotny; Ruth Ottman; Juliann M Paolicchi; Jack M Parent; Kristen Park; Annapurna Poduri; Ingrid E Scheffer; Renée A Shellhaas; Elliott H Sherr; Jerry J Shih; Rani Singh; Joseph Sirven; Michael C Smith; Joseph Sullivan; Liu Lin Thio; Anu Venkat; Eileen P G Vining; Gretchen K Von Allmen; Judith L Weisenberg; Peter Widdess-Walsh; Melodie R Winawer
Journal:  Nature       Date:  2013-08-11       Impact factor: 49.962

10.  POGZ truncating alleles cause syndromic intellectual disability.

Authors:  Janson White; Christine R Beck; Tamar Harel; Jennifer E Posey; Shalini N Jhangiani; Sha Tang; Kelly D Farwell; Zöe Powis; Nancy J Mendelsohn; Janice A Baker; Lynda Pollack; Kati J Mason; Klaas J Wierenga; Daniel K Arrington; Melissa Hall; Apostolos Psychogios; Laura Fairbrother; Magdalena Walkiewicz; Richard E Person; Zhiyv Niu; Jing Zhang; Jill A Rosenfeld; Donna M Muzny; Christine Eng; Arthur L Beaudet; James R Lupski; Eric Boerwinkle; Richard A Gibbs; Yaping Yang; Fan Xia; V Reid Sutton
Journal:  Genome Med       Date:  2016-01-06       Impact factor: 15.266

View more
  19 in total

1.  19p13 microduplications encompassing NFIX are responsible for intellectual disability, short stature and small head circumference.

Authors:  Aurélien Trimouille; Nada Houcinat; Marie-Laure Vuillaume; Patricia Fergelot; Cécile Boucher; Jérôme Toutain; Cédric Le Caignec; Marie Vincent; Mathilde Nizon; Joris Andrieux; Clémence Vanlerberghe; Bruno Delobel; Bénédicte Duban; Sahar Mansour; Emma Baple; Colina McKeown; Gemma Poke; Kate Robertshaw; Eve Fifield; Antonella Fabretto; Vanna Pecile; Paolo Gasparini; Marco Carrozzi; Didier Lacombe; Benoît Arveiler; Caroline Rooryck; Sébastien Moutton
Journal:  Eur J Hum Genet       Date:  2017-11-28       Impact factor: 4.246

2.  IRF2BPL Is Associated with Neurological Phenotypes.

Authors:  Paul C Marcogliese; Vandana Shashi; Rebecca C Spillmann; Nicholas Stong; Jill A Rosenfeld; Mary Kay Koenig; Julián A Martínez-Agosto; Matthew Herzog; Agnes H Chen; Patricia I Dickson; Henry J Lin; Moin U Vera; Noriko Salamon; John M Graham; Damara Ortiz; Elena Infante; Wouter Steyaert; Bart Dermaut; Bruce Poppe; Hyung-Lok Chung; Zhongyuan Zuo; Pei-Tseng Lee; Oguz Kanca; Fan Xia; Yaping Yang; Edward C Smith; Joan Jasien; Sujay Kansagra; Gail Spiridigliozzi; Mays El-Dairi; Robert Lark; Kacie Riley; Dwight D Koeberl; Katie Golden-Grant; Shinya Yamamoto; Michael F Wangler; Ghayda Mirzaa; Dimitri Hemelsoet; Brendan Lee; Stanley F Nelson; David B Goldstein; Hugo J Bellen; Loren D M Pena
Journal:  Am J Hum Genet       Date:  2018-07-26       Impact factor: 11.025

3.  De novo TRIM8 variants impair its protein localization to nuclear bodies and cause developmental delay, epilepsy, and focal segmental glomerulosclerosis.

Authors:  Patricia L Weng; Amar J Majmundar; Kamal Khan; Tze Y Lim; Shirlee Shril; Gina Jin; John Musgrove; Minxian Wang; Dina F Ahram; Vimla S Aggarwal; Louise E Bier; Erin L Heinzen; Ana C Onuchic-Whitford; Nina Mann; Florian Buerger; Ronen Schneider; Konstantin Deutsch; Thomas M Kitzler; Verena Klämbt; Amy Kolb; Youying Mao; Christelle Moufawad El Achkar; Adele Mitrotti; Jeremiah Martino; Bodo B Beck; Janine Altmüller; Marcus R Benz; Shoji Yano; Mohamad A Mikati; Talha Gunduz; Heidi Cope; Vandana Shashi; Howard Trachtman; Monica Bodria; Gianluca Caridi; Isabella Pisani; Enrico Fiaccadori; Asmaa S AbuMaziad; Julian A Martinez-Agosto; Ora Yadin; Jonathan Zuckerman; Arang Kim; Ulrike John-Kroegel; Amanda V Tyndall; Jillian S Parboosingh; A Micheil Innes; Agnieszka Bierzynska; Ania B Koziell; Mordi Muorah; Moin A Saleem; Julia Hoefele; Korbinian M Riedhammer; Ali G Gharavi; Vaidehi Jobanputra; Emma Pierce-Hoffman; Eleanor G Seaby; Anne O'Donnell-Luria; Heidi L Rehm; Shrikant Mane; Vivette D D'Agati; Martin R Pollak; Gian Marco Ghiggeri; Richard P Lifton; David B Goldstein; Erica E Davis; Friedhelm Hildebrandt; Simone Sanna-Cherchi
Journal:  Am J Hum Genet       Date:  2021-01-27       Impact factor: 11.025

Review 4.  Building dialogues between clinical and biomedical research through cross-species collaborations.

Authors:  Hsiao-Tuan Chao; Lucy Liu; Hugo J Bellen
Journal:  Semin Cell Dev Biol       Date:  2017-06-01       Impact factor: 7.727

5.  Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network.

Authors:  Souhrid Mukherjee; Joy D Cogan; John H Newman; John A Phillips; Rizwan Hamid; Jens Meiler; John A Capra
Journal:  Am J Hum Genet       Date:  2021-09-15       Impact factor: 11.025

Review 6.  Epigenetic genes and epilepsy - emerging mechanisms and clinical applications.

Authors:  Karen M J Van Loo; Gemma L Carvill; Albert J Becker; Karen Conboy; Alica M Goldman; Katja Kobow; Iscia Lopes-Cendes; Christopher A Reid; Erwin A van Vliet; David C Henshall
Journal:  Nat Rev Neurol       Date:  2022-07-20       Impact factor: 44.711

7.  A New Approach to Rare Diseases of Children: The Undiagnosed Diseases Network.

Authors:  Chloe M Reuter; Elise Brimble; Colette DeFilippo; Annika M Dries; Gregory M Enns; Euan A Ashley; Jonathan A Bernstein; Paul Graham Fisher; Matthew T Wheeler
Journal:  J Pediatr       Date:  2018-01-11       Impact factor: 4.406

Review 8.  Insights into genetics, human biology and disease gleaned from family based genomic studies.

Authors:  Jennifer E Posey; Anne H O'Donnell-Luria; Jessica X Chong; Tamar Harel; Shalini N Jhangiani; Zeynep H Coban Akdemir; Steven Buyske; Davut Pehlivan; Claudia M B Carvalho; Samantha Baxter; Nara Sobreira; Pengfei Liu; Nan Wu; Jill A Rosenfeld; Sushant Kumar; Dimitri Avramopoulos; Janson J White; Kimberly F Doheny; P Dane Witmer; Corinne Boehm; V Reid Sutton; Donna M Muzny; Eric Boerwinkle; Murat Günel; Deborah A Nickerson; Shrikant Mane; Daniel G MacArthur; Richard A Gibbs; Ada Hamosh; Richard P Lifton; Tara C Matise; Heidi L Rehm; Mark Gerstein; Michael J Bamshad; David Valle; James R Lupski
Journal:  Genet Med       Date:  2019-01-18       Impact factor: 8.822

9.  Rare disease patient matchmaking: development and outcomes of an internet case-finding strategy in the Undiagnosed Diseases Network.

Authors:  Kimberly LeBlanc; Emily G Kelley; Anna Nagy; Jorick Bater; Tala Berro; Molly A McGuinness; Courtney Studwell; Matthew Might
Journal:  Orphanet J Rare Dis       Date:  2021-05-10       Impact factor: 4.123

10.  MiR-361-3p alleviates cerebral ischemia-reperfusion injury by targeting NACC1 through the PINK1/Parkin pathway.

Authors:  Xihong Ye; Hua Song; Huimin Hu; Chunli Zhou; Qinyi Chen; Lin Hong; Min Huang; Hongfei Zhu
Journal:  J Mol Histol       Date:  2022-01-24       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.